Retatrutide to be Tested for Chronic Back Pain in Obese Individuals

Obesity and overweight are pervasive health challenges, frequently linked to a spectrum of comorbidities, including debilitating chronic low back pain (CLBP). The increased mechanical load on the spine, systemic inflammation, and metabolic dysfunction associated with excess body weight are all believed to contribute to the higher prevalence and severity of CLBP in this population. Despite this well-established connection, there remains a significant unmet need for targeted pharmacological interventions that effectively address CLBP specifically within the context of obesity.